Skip to main content
OpenTrials
Completed

NCT Number: NCT00184522

On Demand Treatment of Reflux Disease

A comparison of the effect of on demand treatment with a pectin-containing natural product (Aflurax) with that esomeprazole (Nexium)

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Gastroesophageal Reflux Deglutition Disorders Digestive System Diseases Esophageal Diseases Esophageal Motility Disorders Gastrointestinal Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Gjøvik Specialist Centre, Gjøvik, Norway

Loading trial locations.

About this study

A randomized, controlled, open trial comparing the symptomatic effect of a pectin-containing product (Aflurax) with that of esomeprazole (Nexium 20 mg) given on-demand for 6 weeks.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Mild and moderate reflux symptoms Age > 17 years Informed consent -

Exclusion criteria

Other conditions that might explain the symptoms Abuse of drugs or alcohol

-

Treatment and study plan

Aflurax

Drug

Other names: Pectin-containing nature product

Esomeprazole

Drug

Other names: Nexium

Primary outcomes

  1. Symptomatic relief

Secondary outcomes

  1. Overall satisfaction

Sponsors and collaborators

Lead sponsor

Norwegian University of Science and Technology

Other

Collaborators

  • Ferrosan AS

Registry information

Official study title

Aflurax Versus Nexium Given on Demand to Patients With Gastro-esophageal Reflux Disease.

Important dates

Study start
2002
Primary completion
2004
Study completion
2004
First posted
Sep 16, 2005
Registry last updated
Aug 9, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.